Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial
Citation
RECOVERY Collaborative Group 2022 , ' Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ' , The Lancet , vol. 399 , no. 10325 , pp. 665-676 . https://doi.org/10.1016/S0140-6736(22)00163-5